Chester County News and Community Website
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the recent publication of the 12-month analysis from the BRAVO Study in the Journal of Clinical Medicine.
TELA Bio Announces Publication of 12-Month Results from the BRAVO Study Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced details of the clinical research presented last week at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting in Las …
TELA Bio Announces New Data on Use of OviTex in a Range of Hernia Repair Applications Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced three upcoming poster presentations on its OviTex Reinforced Tissue Matrix portfolio. Data demonstrating the effectiveness of OviTex in a variety of …
TELA Bio’s OviTex Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced the first use of its OviTex LPR Reinforced Tissue Matrix in Europe.
NHS Surgeon First in Europe to Implant TELA Bio’s OviTex LPR Reinforced Tissue Matrix Read More MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue …
TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue …
TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex Read More
MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA), an innovative MedTech company focused on advancing the field of soft-tissue reconstruction, announced that it has welcomed Bruce Freedman, M.D., FACS as …
TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development Read More